164 related articles for article (PubMed ID: 34428351)
1. Out-of-pocket costs associated with head and neck cancer treatment.
Khan MN; Hueniken K; Manojlovic-Kolarski M; Eng L; Mirshams M; Khan K; Simpson C; Au M; Liu G; Xu W; Longo CJ; Goldstein DP; Ringash J; Martino R; Hansen AR; de Almeida JR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1528. PubMed ID: 34428351
[TBL] [Abstract][Full Text] [Related]
2. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
[TBL] [Abstract][Full Text] [Related]
3. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
4. An examination of cancer patients' monthly 'out-of-pocket' costs in Ontario, Canada.
Longo CJ; Deber R; Fitch M; Williams AP; D'Souza D
Eur J Cancer Care (Engl); 2007 Nov; 16(6):500-7. PubMed ID: 17944764
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Ren J; Pang W; Hueniken K; Haddad G; Hope A; Huang SH; Spreafico A; Hansen AR; Perez-Ordonez B; Goldstein DP; Bratman SV; Zhang W; Zhao Y; Xu W; de Almeida JR; Liu G
Cancer; 2022 Feb; 128(3):497-508. PubMed ID: 34597435
[TBL] [Abstract][Full Text] [Related]
6. Patient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patients.
Zheng F; Lavin J; Sprafka JM
J Med Econ; 2021; 24(1):1173-1177. PubMed ID: 34596001
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients.
Sprave T; Verma V; Fabian A; Rühle A; Baltas D; Grosu AL; Nicolay NH
Strahlenther Onkol; 2022 Nov; 198(11):1008-1015. PubMed ID: 35833963
[TBL] [Abstract][Full Text] [Related]
8. Out-of-Pocket Costs for Patients Undergoing Thyroid Surgery.
Zheng F; Huang Y; Wright J; Kuo JH
Ann Surg; 2022 Dec; 276(6):e937-e943. PubMed ID: 34261887
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors.
Massa ST; Osazuwa-Peters N; Adjei Boakye E; Walker RJ; Ward GM
JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):239-249. PubMed ID: 30789634
[TBL] [Abstract][Full Text] [Related]
10. Financial and family burden associated with cancer treatment in Ontario, Canada.
Longo CJ; Fitch M; Deber RB; Williams AP
Support Care Cancer; 2006 Nov; 14(11):1077-85. PubMed ID: 16896878
[TBL] [Abstract][Full Text] [Related]
11. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.
Tom MC; Ross RB; Koyfman SA; Adelstein DJ; Lorenz RR; Burkey BB; Shah C; Suh JH; Bolwell BJ; Savage C; Platz S; Ward MC
J Oncol Pract; 2019 Jun; 15(6):e560-e567. PubMed ID: 31009283
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
13. Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer.
Smith J; Yu J; Gordon LG; Chilkuri M
Curr Oncol; 2023 May; 30(5):4922-4935. PubMed ID: 37232829
[TBL] [Abstract][Full Text] [Related]
14. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
15. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
17. Impact of treatment modality on quality of life of head and neck cancer patients: Findings from an academic medical institution.
Christopher KM; Osazuwa-Peters N; Dougherty R; Indergaard SA; Popp C; Walker R; Varvares MA
Am J Otolaryngol; 2017; 38(2):168-173. PubMed ID: 28081981
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada.
Longo CJ; Bereza BG
Curr Oncol; 2011 Jan; 18(1):e1-8. PubMed ID: 21331267
[TBL] [Abstract][Full Text] [Related]
20. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
Waddle MR; Ma DJ; Visscher SL; Borah BJ; May JM; Price KA; Moore EJ; Patel SH; Hinni ML; Chintakuntlawar AV; Garcia JJ; Graner DE; Neben-Wittich MA; Garces YI; Hallemeier CL; Price DL; Kasperbauer JL; Janus JR; Foote RL; Miller RC
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):396-402. PubMed ID: 33359567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
